» Articles » PMID: 37425476

Impact of Antithrombotic Therapy on Clinical Outcomes in Patients with Type B Acute Aortic Syndrome

Overview
Journal JTCVS Open
Date 2023 Jul 10
PMID 37425476
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Antithrombotic therapy has the potential to interfere with false lumen thrombosis. In type B acute aortic syndrome, the degree of false lumen thrombosis affects clinical outcomes. We aimed to explore the association of antithrombotic therapy with the prognosis of patients with type B acute aortic syndrome.

Methods: We reviewed 406 patients with type B acute aortic syndrome who were discharged alive with and without antithrombotic therapy. The primary outcome was aorta-related adverse events, defined as a composite of aorta-related death, aortic rupture, aortic repair, and progressive aortic dilation.

Results: Of the 406 patients, 64 (16%) were discharged with antithrombotic therapy and 342 (84%) were discharged without antithrombotic therapy. A total of 249 patients (61%) presented with intramural hematoma with complete thrombosis of the false lumen, and 157 patients (39%) presented with aortic dissection. During a median follow-up of 4.6 years, 32 patients (50%) in the antithrombotic group and 93 patients (27%) in the nonantithrombotic group had a primary outcome event. Cumulative incidence of aorta-related events at 1 and 3 years with death as the competing risk was higher in the antithrombotic group than in the nonantithrombotic group (19% ± 5% vs 9% ± 2% at 1 year and 40% ± 7% vs 17% ± 2% at 3 years,  < .001).

Conclusions: Antithrombotic therapy might be associated with an increased risk of aorta-related events in patients with type B acute aortic syndrome.

Citing Articles

The application of 5E rehabilitation management mode in the nursing of patients with aortic dissection complicated by obstructive sleep apnea.

Huang L, Yang Y, Guo J, Huang Y, Lin L Sleep Breath. 2023; 28(3):1089-1097.

PMID: 38157125 PMC: 11196331. DOI: 10.1007/s11325-023-02977-z.

References
1.
Miyoshi Y, Kaji S, Masumoto A, Kim K, Kitai T, Kinoshita M . Aortic enlargement in two weeks is associated with subsequent aortic events in patients with type B acute aortic syndrome. J Thorac Cardiovasc Surg. 2021; 166(2):410-418.e1. DOI: 10.1016/j.jtcvs.2021.09.014. View

2.
Chung J, Elkins C, Sakai T, Kato N, Vestring T, Semba C . True-lumen collapse in aortic dissection: part I. Evaluation of causative factors in phantoms with pulsatile flow. Radiology. 2000; 214(1):87-98. DOI: 10.1148/radiology.214.1.r00ja3287. View

3.
Akutsu K, Nejima J, Kiuchi K, Sasaki K, Ochi M, Tanaka K . Effects of the patent false lumen on the long-term outcome of type B acute aortic dissection. Eur J Cardiothorac Surg. 2004; 26(2):359-66. DOI: 10.1016/j.ejcts.2004.03.026. View

4.
Di Eusanio M, Trimarchi S, Patel H, Hutchison S, Suzuki T, Peterson M . Clinical presentation, management, and short-term outcome of patients with type A acute dissection complicated by mesenteric malperfusion: observations from the International Registry of Acute Aortic Dissection. J Thorac Cardiovasc Surg. 2012; 145(2):385-390.e1. DOI: 10.1016/j.jtcvs.2012.01.042. View

5.
Nienaber C, Kische S, Rousseau H, Eggebrecht H, Rehders T, Kundt G . Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv. 2013; 6(4):407-16. DOI: 10.1161/CIRCINTERVENTIONS.113.000463. View